| Accession Number: | 0001516551-23-000093 |
| Date: | 2023-11-06 |
| Issuer: | SKYE BIOSCIENCE, INC. (SKYE) |
| Original Submission Date: |
GRAYSON PAUL A.
C/O SKYE BIOSCIENCE, INC.
1250 EL CAMINO REAL SUITE 100
SAN DIEGO, CA 92130
| Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
|---|---|---|---|---|---|---|---|---|---|
| COMMON STOCK | 2023-11-06 | A | 173,721 | a | $0.00 | 246,252 | direct |
| Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
|---|
| ID | footnote |
|---|---|
| f1 | represents a restricted stock unit ("rsu") award that vests on the following performance milestones : 25% vests upon achieving a market cap of $125m, an additional 25% vests upon achieving a market cap of $250m, an additional 25% vests upon achieving a market cap of $400m, an additional 25% vest at an exit of $500m or greater; provided, however, that no rsus shall vest until the compensation committee of the issuer determines that shares can be sold into the market to cover withholding tax obligations associated with the vesting of the rsus. notwithstanding anything to the foregoing, all of the rsus shall vest if an exit greater than $500m is achieved at an earlier date. |
| f2 | each rsu represents a contingent right to receive one share of the issuer's common stock. |
